Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extracellular matrix components in breast carcinomas.

Anna Kadar1, Anna-Mária Tõkés, Janina Kulka

  • 12nd Department of Pathology, Semmelweis University of Medicine, Ulloi ut 93, 1091 Budapest, Hungary. ka@korb2.sote.hu

Seminars in Cancer Biology
|June 27, 2002
PubMed
Summary

Malignant processes disrupt extracellular matrix (ECM) production, altering tissue structure. Cancer cells can directly produce or indirectly influence ECM components, impacting tumor progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Knockout of PARP2 in T cells leads to spontaneous colitis with distinct segmental characteristics in PARP1-deficient mice.

Frontiers in immunology·2026
Same author

Deep-learning-based breast cancer stage prediction from H&E-stained whole-slide images in resource-constrained settings.

Journal of pathology informatics·2026
Same author

[Dr. Anna Kádár pathology professor (1935-2024)].

Orvosi hetilap·2026
Same author

International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

[Pathological diagnosis, work-up and reporting of breast cancer. Recommendations of the 5th Hungarian Consensus Conference on Breast Cancer].

Magyar onkologia·2025
Same author

Differential PCNA Expression Between Neoplastic and Adjacent Mucosa as a Prognostic Marker in Colorectal Adenoma-Carcinoma Progression.

Anticancer research·2025

Area of Science:

  • Oncology
  • Biochemistry
  • Cell Biology

Background:

  • Malignant processes disrupt normal extracellular matrix (ECM) biosynthesis.
  • Cancer cells can alter ECM structure and composition through direct production or indirect signaling.
  • Environmental factors may also influence mesenchymal cells, affecting ECM.

Purpose of the Study:

  • To explore how malignant processes interfere with ECM biosynthesis.
  • To examine the consequences of ECM modification on tissue structure and cancer progression.
  • To highlight specific examples of altered ECM production in tumors.

Main Methods:

  • Review of existing literature on cancer and ECM interactions.
  • Analysis of molecular mechanisms underlying ECM dysregulation in cancer.

Related Experiment Videos

  • Case study examples of specific matrix macromolecule production by tumors.

    • Main Results:

    • Malignant cells can directly synthesize ECM components like elastin, tenascin, and osteopontin.
    • Tumor-derived factors can interfere with the regulation of normal ECM production.
    • Altered ECM composition can feedback and influence the malignant process.

    Conclusions:

    • Disruption of ECM biosynthesis is a hallmark of malignant processes.
    • Understanding cancer-associated ECM changes offers new therapeutic targets.
    • The interplay between cancer research and matrix biology is a promising area for future investigation.